Blog

Tag: Metformin

HE4 in ovarian and uterine cancer

A couple of years we introduced HE4 as a tumour marker for pelvic masses. The idea was to differentiate benign ovarian masses from ovarian cancer in patients without ascites or...

Read more about 'HE4 in ovarian and uterine cancer'...

feMME Trial now open

The feMME trial will treat women with endometrial cancer and preserve the patient’s fertility at the same time.

Read more about 'feMME Trial now open'...